Guide
startupperformance marketingvideo adspaid acquisitionVideo Ads for HealthTech: [2026] Performance Guide
If you're running a healthtech & medtech startups, paid acquisition looks completely different to other startup types. Here's the real data on CAC, which platforms work at which stage, and the one mistake that burns most healthtech & medtech startups ad budgets.
Unit Economics You Need to Know Before Spending
| Feature | Details |
|---|---|
| Average CAC via paid | B2C health apps: $15–$60 |
| B2B clinical tools | $800–$5,000 |
| Direct-to-patient medical devices | $120–$400. |
| LTV | CAC target: B2C health app: $9.99/mo × 18mo = $180 LTV → $45–$60 CAC |
| B2B clinical | $500/mo × 36mo = $18k LTV → $3,000–$5,000 CAC (sales-assisted). |
| Stage to start | Post-510(k) or post-CE mark for medical devices; post-HIPAA compliance for health apps |
Platform & Format Strategy
| Feature | Details |
|---|---|
| Best platform | Google Search (health queries are high-intent and high-volume); Meta (lookalike of existing users, broad health interest targeting); LinkedIn for B2B clinical |
| Best ad format | Outcome-focused testimonial, Before/After (health metric improvement), Product demo showing simplicity |
| Channel order | Google Search (health intent searches) |
| Budget at stage | B2C app seed: $3k–$8k/month testing |
| Growth | $15k–$60k/month |
| B2B | $2k–$5k/month (primarily content + sales, paid is supplementary). |
Meta retargeting (of website visitors only — cold targeting is expensive).
LinkedIn for B2B clinical tools only..
The Core Creative Challenge
Health claims in ads are heavily regulated — FTC, FDA, and platform policies restrict before/after imagery, disease treatment claims, and outcome guarantees. Every creative must be compliance-reviewed before shipping to avoid account bans.
What Separates Winners From Wasted Spend
Clinical credibility markers — 'developed with NHS physiotherapists', 'based on 12 clinical studies', 'used by 3,200 GPs' — do more conversion work in health than in any other category. Without credibility signals, health ads look like scams.
The FluxNote Workflow for This Vertical
Build a credibility library first: get quotes from medical advisors, collect clinical citations, photograph any certifications → use these in every video ad as animated text overlays → FluxNote formats them into professional clinical-looking testimonial videos
The Mistake That Burns Budgets
Making health outcome claims you can't substantiate. One FTC enforcement action or Facebook ad ban for medical claims can shut down your acquisition channel permanently during the most critical growth phase.
Pro Tips
- Target CAC: B2C health apps: $15–$60
- Channel order: Google Search (health intent searches)
- Clinical credibility markers — 'developed with NHS physiotherapists', 'based on 12 clinical studies', 'used by 3,200 GPs' — do more conversion work in
- Avoid: Making health outcome claims you can't substantiate. One FTC enforcement action or Facebook ad ban for medical claims can shut down your acquisition c
Create Videos With AI
50,000+ creators already generating videos with FluxNote
★★★★★ 4.9 rating
Turn this into a video — in 2 minutes
FluxNote turns any idea into a publish-ready short-form video. Script, voiceover, captions, footage & music — all AI, no editing.
Frequently Asked Questions
What should my CAC target be for a healthtech & medtech startups?
B2C health apps: $15–$60. B2B clinical tools: $800–$5,000. Direct-to-patient medical devices: $120–$400.. The LTV:CAC rule: B2C health app: $9.99/mo × 18mo = $180 LTV → $45–$60 CAC. B2B clinical: $500/mo × 36mo = $18k LTV → $3,000–$5,000 CAC (sales-assisted).
Which platform works best for healthtech & medtech startups ads?
Google Search (health queries are high-intent and high-volume); Meta (lookalike of existing users, broad health interest targeting); LinkedIn for B2B clinical
What's the biggest creative mistake healthtech & medtech startups make?
Making health outcome claims you can't substantiate. One FTC enforcement action or Facebook ad ban for medical claims can shut down your acquisition channel permanently during the most critical growth phase.